The robots approved to assist in NHS surgeries - and when they will be used
State-of-the-art robotic systems approved for use on the NHS could transform treatment for thousands of people across England.
The technology, given the green light by the National Institute for Health and Care Excellence (Nice) under its early value assessment programme, offers a range of applications, from helping remove tumours to replacing a patient's knee.
The rollout is expected to reduce hospital stays, faster recovery times, and a lower risk of complications.
A total of 11 systems have been approved, including five for soft tissue surgeries, such as removing tumours, repairing hernias and removing gallbladders and six for orthopaedics, including knee and hip replacements.
Some allow surgeons to perform operations using mechanical arms controlled from a console, while others are hand-held.
Dr Anastasia Chalkidou, programme director of Nice's HealthTech programme, said: 'These innovative technologies have the potential to transform both soft tissue and orthopaedic surgical care in the NHS.
'Robot-assisted surgery may help overcome key limitations of conventional techniques through precise movements and enhanced 3D visualisation, potentially transforming surgical options and outcomes for NHS patients.
'Both applications could benefit patients who might not otherwise be candidates for minimally invasive approaches.'
Under the guidance, the 11 systems can be used over the coming three years while more evidence is collected.
Among the issues Nice will look at are how the technology affects the length of hospital stays and waiting lists, as well as the resources used for training staff and the costs of implementing the systems.
Each of the systems costs between £500,000 and £1.5 million, according to the NHS spending watchdog, and are usually deployed in specialist centres where hundreds of operations take place each year.
Dr Chalkidou added: 'The data gathered over the next three years will allow us to evaluate exactly how these technologies can improve patient care and help ensure NHS resources are directed toward interventions that deliver meaningful clinical benefits and long-term value to our health service.'
In 2011-12, the majority of robot-assisted procedures were for urological cancer, which can include cancer in the bladder, kidney, prostate and testicles, according to Nice.
By last year, almost half of these operations were for other conditions, with a surge in the use of robotic surgeries for bowel cancer, which now accounts for a quarter of all robot-assisted procedures.
There has also been a jump in the use of the technology in orthopaedics, with 4,000 robot-assisted surgeries taking place last year, up from 300 in 2018-19.
Making greater use of digital technologies in the NHS is one of the three shifts set to be outlined by the Government in its forthcoming 10-year health plan.
It is also expected to focus more on sickness prevention and moving care from hospitals into the community.
Professor Sir Stephen Powis, national medical director at NHS England, said: 'This is fantastic news for patients and shows that the NHS continues to find new ways to utilise the latest technological innovations to improve care.
'This will be a vital element of the 10-year health plan which will be published in the coming months.
'Robot-assisted surgery is crucial to the future of high-quality healthcare – and with benefits including shorter stays in hospital, faster recovery for patients and less invasive procedures, these advancements will have a knock-on effect throughout the system and help patients get treated quicker.
'This is an important step forward as we continue to work to ensure everyone is able to get high-quality care when they need it.'
Nuha Yassin, a consultant colorectal surgeon and Royal College of Surgeons of England council member, described the Nice guidance as a 'significant step forward'.
'The potential for faster recovery times, reduced complications and increased access to minimally invasive procedures could transform patient care,' she said.
'It remains important that, in introducing these new technologies, NHS trusts and surgical teams ensure they are working within the guidelines set out by the Royal College of Surgeons of England, so that they are implemented in the safest way possible for patients.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Argus
2 hours ago
- South Wales Argus
Recommendations made on reducing Gwent hospital delays
Leanne Watkins said she backed a recommendation for a joint IT system between the NHS and local authorities which are responsible for providing care at home and placing people into residential care homes. The recommendation is one of 11 made following an extensive audit of the process for discharging patients stuck in hospitals across Gwent despite being well enough to leave. Audit Wales looked at how the area's Aneurin Bevan University Health Board worked with its five local authorities, Blaenau Gwent, Caerphilly, Monmouthshire, Newport and Torfaen , with figures from 2023/24 examined. This is how the 'score on the door' food hygiene ratings are worked out Councils to use AI translations but 'tech bros need better Welsh' Ms Watkins is part of an 'integrated team' of NHS and council social services staff based at Monnow Vale the community hospital in Monmouth and told Monmouthshire County Council's scrutiny committee: 'I agree we need to streamline good practice and IT that would be a huge benefit. 'I currently have to have three computers just to understand social services, and for colleagues to have a health computer, it shouldn't be happening in this day and age when you've got an integrated team.' Ms Watkins said at present the patient with the longest stay in Monnow Vale has been there 40 days but before the integrated team came into the hospital its longest stay was 365 days, meaning a patient had spent a full year in hospital. The longest say in Abergavenny's Nevill Hall is currently 66 days due to 'complex issues' but Ms Watkins said the patient has a clear discharge plan. Jenny Jenkins, Monmouthshire's head of adult services, said the Audit Wales report showed there are on average 250 patients a month in Gwent hospitals who with the right support at home, or a care home place, could leave but unable to do so. That cost the Aneurin Bevan board around £27m a year based on an average bed cost of £500. The figure for patients from Monmouthshire is around 53 a month, which Ms Jenkins described as 'about a fifth' of the Gwent total. Figures have improved over the past year and the Monmouthshire figure for May this year was 51. Ms Jenkins said there is a trend in reducing the length of delays. READ MORE: NHS winter plan agreed by Aneurin Bevan Health Board The top five social care reasons for delayed discharge for Monmouthshire residents are awaiting a joint assessment that needs a social care and health assessment, waiting for a nursing home place to be available, waiting for a social care assessment, needing a home care package to be put in place and for a care home manager to make an assessment. Audit Wales, which has conducting reviews for all health board areas, has made recommendations on discharge planning, discharging patients over seven days which has been trialed in Gwent, clarifying what care will be put in place, for the health board to review how it approaches 'risk' so beds aren't 'unnecessarily' occupied and how its policies are applied. It also said the quality and sharing of information needs to be improved including sharing IT and ultimately a joint system and how patient and carers' experience is recorded.
South Wales Guardian
3 hours ago
- South Wales Guardian
NHS launches new drive to find more people with deadly pancreatic cancer
Hundreds of GP practices in England are being given extra funding to comb patient records looking for people with the disease, which has the lowest survival rate of all cancers. GPs and their teams will look for people over 60 who may have signs of the cancer, such as a recent diagnosis of diabetes and sudden weight loss. Figure suggest that around half of people diagnosed with pancreatic cancer have been diagnosed with type 1 or 2 diabetes recently. Family doctors taking part in the NHS England pilot will then contact patients and send them for urgent blood tests and CT scans to rule cancer in or out. Pancreatic cancer can have vague symptoms and is often diagnosed in the late stages. According to researchers, newly-diagnosed diabetes patients often have similar symptoms as a person with early-stage pancreatic cancer. This is because the cancer destroys the same insulin-producing cells that are also destroyed in diabetes. Around 10,500 people in the UK are diagnosed with pancreatic cancer every year and only around one in 20 survive the disease for 10 years or more. More than half of people die within three months of diagnosis. For the new three-year pilot, more than 300 GP practices in England will be involved, with all practices up and running by the autumn. Almost £2 million in targeted funding has been invested to help practices find people most at risk and give patients the best chance of being diagnosed early. Professor Peter Johnson, NHS national clinical director for cancer, said: 'Pancreatic cancer is responsible for so many deaths because patients don't usually notice symptoms until the cancer is at an advanced stage, which is why we need to find new ways to pick it up. 'Through initiatives like this and the upcoming 10-year health plan, the NHS is determined to go a step further – not just treat people at an advanced stage but to go out into communities and seek people out who might be unwell without any symptoms so we can provide people with the most effective treatment. 'The NHS is seeing and treating more people with cancer than ever, and early diagnosis is key to ensure patients have the best chance of receiving effective treatment. 'If your GP practice identifies you as at risk of pancreatic cancer, I urge you to come forward for testing as soon as possible.' Health minister Karin Smyth said: 'This targeted approach to identify people at risk of one of the most lethal cancers could give more people a fighting chance and spare the heartbreak of countless families.' We're delighted to see the Government commit to boosting clinical trials as part of their forthcoming 10 year plan. Clinical trials are a crucial treatment option for people with #PancreaticCancer & improving access to them could be key to driving up treatment & survival rates 🧪 — Pancreatic Cancer UK (@PancreaticCanUK) June 16, 2025 Alfie Bailey-Bearfield, head of influencing and health improvement at Pancreatic Cancer UK, said: 'Diagnosing more people with pancreatic cancer earlier, when the disease is most treatable, would make the single biggest difference to improving survival, so we are delighted to see significant further investment from NHS England towards that incredibly important goal. 'We're proud to have been involved in shaping this new case finding pilot, which will support GPs to proactively find people with pancreatic cancer among one of largest groups known to be at increased risk: those aged over 60, with new onset diabetes who have recently lost weight without trying to do so. 'Many of the people who are referred for a CT scan during the pilot will not have pancreatic cancer, but for those that do, the impact could be lifesaving. 'Subject to the pilot's success, we will be calling for this pilot to be expanded across the country to help give more people affected by the deadliest common cancer the very best chance of survival.' Previous research has shown that people over 50 with a new case of type 2 diabetes have a higher chance of being diagnosed with pancreatic cancer within three years.
North Wales Chronicle
3 hours ago
- North Wales Chronicle
NHS launches new drive to find more people with deadly pancreatic cancer
Hundreds of GP practices in England are being given extra funding to comb patient records looking for people with the disease, which has the lowest survival rate of all cancers. GPs and their teams will look for people over 60 who may have signs of the cancer, such as a recent diagnosis of diabetes and sudden weight loss. Figure suggest that around half of people diagnosed with pancreatic cancer have been diagnosed with type 1 or 2 diabetes recently. Family doctors taking part in the NHS England pilot will then contact patients and send them for urgent blood tests and CT scans to rule cancer in or out. Pancreatic cancer can have vague symptoms and is often diagnosed in the late stages. According to researchers, newly-diagnosed diabetes patients often have similar symptoms as a person with early-stage pancreatic cancer. This is because the cancer destroys the same insulin-producing cells that are also destroyed in diabetes. Around 10,500 people in the UK are diagnosed with pancreatic cancer every year and only around one in 20 survive the disease for 10 years or more. More than half of people die within three months of diagnosis. For the new three-year pilot, more than 300 GP practices in England will be involved, with all practices up and running by the autumn. Almost £2 million in targeted funding has been invested to help practices find people most at risk and give patients the best chance of being diagnosed early. Professor Peter Johnson, NHS national clinical director for cancer, said: 'Pancreatic cancer is responsible for so many deaths because patients don't usually notice symptoms until the cancer is at an advanced stage, which is why we need to find new ways to pick it up. 'Through initiatives like this and the upcoming 10-year health plan, the NHS is determined to go a step further – not just treat people at an advanced stage but to go out into communities and seek people out who might be unwell without any symptoms so we can provide people with the most effective treatment. 'The NHS is seeing and treating more people with cancer than ever, and early diagnosis is key to ensure patients have the best chance of receiving effective treatment. 'If your GP practice identifies you as at risk of pancreatic cancer, I urge you to come forward for testing as soon as possible.' Health minister Karin Smyth said: 'This targeted approach to identify people at risk of one of the most lethal cancers could give more people a fighting chance and spare the heartbreak of countless families.' We're delighted to see the Government commit to boosting clinical trials as part of their forthcoming 10 year plan. Clinical trials are a crucial treatment option for people with #PancreaticCancer & improving access to them could be key to driving up treatment & survival rates 🧪 — Pancreatic Cancer UK (@PancreaticCanUK) June 16, 2025 Alfie Bailey-Bearfield, head of influencing and health improvement at Pancreatic Cancer UK, said: 'Diagnosing more people with pancreatic cancer earlier, when the disease is most treatable, would make the single biggest difference to improving survival, so we are delighted to see significant further investment from NHS England towards that incredibly important goal. 'We're proud to have been involved in shaping this new case finding pilot, which will support GPs to proactively find people with pancreatic cancer among one of largest groups known to be at increased risk: those aged over 60, with new onset diabetes who have recently lost weight without trying to do so. 'Many of the people who are referred for a CT scan during the pilot will not have pancreatic cancer, but for those that do, the impact could be lifesaving. 'Subject to the pilot's success, we will be calling for this pilot to be expanded across the country to help give more people affected by the deadliest common cancer the very best chance of survival.' Previous research has shown that people over 50 with a new case of type 2 diabetes have a higher chance of being diagnosed with pancreatic cancer within three years.
